Day Gain | ||
Gain | ||
Market Val | ||
Costs | ||
Cash | ||
Portfolio | ||
Realized | ||
Dividend |
Novo, Teva, AstraZeneca issued FTC warnings over 'bogus' patents (NYSE:TEVA) | news.google.com • |
GSK: 3 Top Pharma Stocks for May 2024 | news.google.com • |
abrdn plc Grows Stock Position in Teva Pharmaceutical Industries Limited (NYSE:TEVA) | news.google.com • |
Teva Pharmaceutical Industries (WBO:TEVA) 3-Year Revenue Growth Rate : -2.40% (As of Dec. 2023) | news.google.com • |
Teva Pharmaceutical Industries (WBO:TEVA) 50-Day SMA : €12.45 (As of Apr. 26, 2024) | news.google.com • |
You Would Fire “God” As Your Portfolio Manager | investorplace.com • |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-05-08 | 2024-03 | 0.51 | N/A | N/A | N/A |
2024-01-31 | 2023-12 | 0.75 | 1 | 0.25 | 33.33% |
2023-11-08 | 2023-09 | 0.6 | 0.6 | N/A | N/A |
2023-08-02 | 2023-06 | 0.54 | 0.56 | 0.02 | 3.70% |
2023-05-10 | 2023-03 | 0.57 | 0.4 | -0.17 | -29.82% |
2023-02-08 | 2022-12 | 0.68 | 0.71 | 0.03 | 4.41% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-09-19 | UBS | Upgrade | Neutral | Neutral |
2023-09-07 | B of A Securities | Upgrade | Buy | Buy |
2023-07-05 | UBS | Upgrade | Sell | Neutral |
2023-05-24 | Morgan Stanley | Upgrade | Equal-Weight | |
2023-05-17 | Evercore ISI Group | Upgrade | In-Line | Outperform |
2023-05-10 | B of A Securities | Upgrade | Buy | Buy |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2024-02-27 | BERGWERK DOV | Officer | 96.98K | Conversion of Exercise of derivative security |
2024-03-03 | DRAPE ERIC | Officer | 77.93K | Conversion of Exercise of derivative security |
2024-03-03 | FRANCIS RICHARD D | Chief Executive Officer | 123.30K | Sale |
2024-03-03 | KALIF ELIYAHU SHARON | Chief Financial Officer | 207.53K | Conversion of Exercise of derivative security |
2024-03-04 | SABAG MARK | Officer | 382.59K | Sale |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Blackrock Inc. | 40.29M | 303.38M | 3.59% |
2023-06-29 | Phoenix Holdings Ltd. | 33.70M | 253.79M | 3.01% |
2023-06-29 | Ion Asset Management Limited | 33.06M | 248.96M | 2.95% |
2023-06-29 | Clal Insurance Enterprises Holdings Ltd | 31.61M | 238.06M | 2.82% |
2023-06-29 | Menora Mivtachim Holdings Ltd. | 26.58M | 200.14M | 2.37% |
2023-06-29 | Lingotto Investment Management Llp | 24.21M | 182.33M | 2.16% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-09-29 | Fundamental Investors Inc | 6.73M | 68.62M | 0.60% |
2023-08-30 | iShares Core MSCI EAFE ETF | 6.19M | 60.43M | 0.55% |
2023-09-29 | iShares MSCI Eafe ETF | 3.52M | 35.90M | 0.31% |
2023-07-30 | New World Fund, Inc. | 2.98M | 25.03M | 0.27% |
2023-05-30 | Fidelity International Index Fund | 2.91M | 20.94M | 0.26% |
2023-09-29 | iShares MSCI Eafe Value ETF | 2.51M | 25.56M | 0.22% |
Dividend | Date |
---|---|
0.085 | 2017-11-27 |
0.085 | 2017-08-25 |
0.34 | 2017-06-01 |
0.34 | 2017-02-28 |
0.34 | 2016-12-01 |
0.34 | 2016-08-18 |
Split | Date |
---|---|
2 : 1 | 2004-07-01 |
2 : 1 | 2002-12-06 |
2 : 1 | 2000-02-23 |
2 : 1 | 1993-04-14 |
1 : 1 | 1982-08-16 |
-
$TEVA very well said M. Thank you for being humble about it
-
The deal with Sanofi is $1.5 for 60% then Teva got $1.5 plus the value for the other 50% at least $1.5…
$3B only from this drug… -
9, 12 , 15 ——> 24
-
Earning $9.5
-
$8 end of the day
-
To the moon
-
to the moon
-
towards 9
-
-
#Brilliant with all that boxing in of settlements. Given the inflationary outlook for years to come, the debt and settlement liabilities will diminish significantly compared to future pricing development when discounted in todays value
-
$TEVA. Is it true that Buffet got rid of all his shares?
-
Net debt down $2.8B and FCF is $2.2B maybe the balance is the 0.5B redemption of convertible bonds.
-
1-2 months of Patience equals to $11-12
6 months of Patience equals to $14-18
Year or two of Patience equals to $22-25
-
-
TEVA settled global litigation, news just out
-
Above 10 today
-
️️️️
-
To the moon
-
GSK: 3 Top Pharma Stocks for May 2024
news.google.com • -
You Would Fire “God” As Your Portfolio Manager
investorplace.com • -
6 reasons to buy Teva Pharmaceuticals stock sooner than later
marketbeat.com • -
Teva Pharma CEO Richard Francis on Q4 earnings
youtube.com • -
Teva to divest active pharmaceutical ingredient business
reuters.com • -
Small mid cap biotech, pharma stocks set for better 2024: analysts
proactiveinvestors.com • -
Corcept Therapeutics shares sink after losing patent infringement lawsuit against Teva
proactiveinvestors.com • -
Corcept stock drops after drugmaker loses patent lawsuit against Teva
marketwatch.com • -
Teva to Present at the 42nd Annual J.P. Morgan Healthcare Conference
businesswire.com • -
Indivior settles patent wrangle with Teva subsidiary
proactiveinvestors.co.uk • -
Teva: 4 Key Drivers For A 2024 Revival (Upgraded Rating)
seekingalpha.com • -
Teva Pharma is the way to play the re-rise of generic drugs
marketbeat.com • -
Teva Pharmaceutical analysts boost target price as brand transition underway
proactiveinvestors.com • -
Teva to Present at the 6th Annual Evercore ISI HealthCONx Conference
businesswire.com • -
2 overlooked stocks that crushed earnings but traded lower
marketbeat.com • -
Teva Pharmaceutical Industries (TEVA) Q3 2023 Earnings Call Transcript
seekingalpha.com • -
Teva shares climb as third-quarter sales top estimates
marketwatch.com • -
Teva Pharm Q3 profit rises, sees higher 2023 revenue
reuters.com • -
Israeli Stocks Fall as Investors Fear Middle East Conflict
investorplace.com • -
These Israeli pharmaceutical stocks are down in the wake of Hamas attack
marketwatch.com • -
Teva partnership with Sanofi ‘will pay dividends,' analyst says
marketwatch.com • -
TEVA: A Pharmaceutical Stock to Watch Right Now
seeitmarket.com • -
Teva Pharma lands US$225 million fine for price-fixing
proactiveinvestors.co.uk • -
Teva agrees to pay $126 mln to US hospitals over opioids
reuters.com • -
Teva CEO Richard Francis on Q2 earnings beat
youtube.com • -
Teva Pharmaceuticals and Alvotech expand biosimilars partnership
marketwatch.com • -
Teva Pharmaceutical's Remarkable Growth In 2023: A Success Story
seekingalpha.com • -
Teva Pharmaceuticals upgraded with improving product mix set to bolster gross margins
proactiveinvestors.com • -
3 Bargain Stocks to Buy on the Dip
fool.com • -
Teva Pharmaceutical settles $193M opioid suit with the state of Nevada
proactiveinvestors.com • -
Teva Will Slim Down Its Generic Drug Business
barrons.com • -
Why Is Teva Pharmaceuticals (TEVA) Stock Up Today?
investorplace.com • -
Teva Pharmaceutical Is Stabilizing Hinting A Payoff Potential
seekingalpha.com • -
Catalyst Pharma And Teva's ANDA Challenge: Firdapse Hangs By A Thread
seekingalpha.com • -
7 Strong Buy Stocks Under $10 to Snap Up Now
investorplace.com • -
Francisco Garcia Parames' Cobas Funds 4th-Quater Letter
gurufocus.com • -
Competition Coming For AbbVie's Blockbuster Humira
seekingalpha.com • -
What To Expect From Teva Pharmaceutical In 2023 With A New CEO
seekingalpha.com • -
Top Trades of David Abrams' Firm in the 4th Quarter
gurufocus.com • -
Axsome Therapeutics (AXSM) Stock Falls as Teva Pursues Generic Depression Drug
investorplace.com •